SK14592001A3 - Antiidiotypová protilátka k protilátke inhibujúcej väzbu imunoglobulínu E na jeho receptor s vysokou afinitou a farmaceutický prípravok obsahujúci túto protilátku - Google Patents

Antiidiotypová protilátka k protilátke inhibujúcej väzbu imunoglobulínu E na jeho receptor s vysokou afinitou a farmaceutický prípravok obsahujúci túto protilátku Download PDF

Info

Publication number
SK14592001A3
SK14592001A3 SK1459-2001A SK14592001A SK14592001A3 SK 14592001 A3 SK14592001 A3 SK 14592001A3 SK 14592001 A SK14592001 A SK 14592001A SK 14592001 A3 SK14592001 A3 SK 14592001A3
Authority
SK
Slovakia
Prior art keywords
ser
ige
thr
gly
seq
Prior art date
Application number
SK1459-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Franz Kricek
Beda Stadler
Monique Vogel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK14592001A3 publication Critical patent/SK14592001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK1459-2001A 1999-04-14 2000-04-12 Antiidiotypová protilátka k protilátke inhibujúcej väzbu imunoglobulínu E na jeho receptor s vysokou afinitou a farmaceutický prípravok obsahujúci túto protilátku SK14592001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds
PCT/EP2000/003288 WO2000063252A1 (en) 1999-04-14 2000-04-12 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor

Publications (1)

Publication Number Publication Date
SK14592001A3 true SK14592001A3 (sk) 2002-05-09

Family

ID=10851525

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1459-2001A SK14592001A3 (sk) 1999-04-14 2000-04-12 Antiidiotypová protilátka k protilátke inhibujúcej väzbu imunoglobulínu E na jeho receptor s vysokou afinitou a farmaceutický prípravok obsahujúci túto protilátku

Country Status (29)

Country Link
US (1) US7041288B2 (de)
EP (1) EP1169353B1 (de)
JP (1) JP4109829B2 (de)
KR (1) KR100492202B1 (de)
CN (1) CN1268644C (de)
AR (1) AR029624A1 (de)
AT (1) ATE392437T1 (de)
AU (1) AU767712B2 (de)
BR (1) BR0009781A (de)
CA (1) CA2363991C (de)
CO (1) CO5241329A1 (de)
CZ (1) CZ20013673A3 (de)
DE (1) DE60038608T2 (de)
ES (1) ES2302693T3 (de)
GB (1) GB9908533D0 (de)
HK (1) HK1044544B (de)
HU (1) HUP0200713A2 (de)
IL (2) IL145507A0 (de)
MX (1) MXPA01010348A (de)
MY (1) MY141459A (de)
NO (1) NO20014936L (de)
PE (1) PE20010046A1 (de)
PL (1) PL350676A1 (de)
PT (1) PT1169353E (de)
RU (1) RU2253655C2 (de)
SK (1) SK14592001A3 (de)
TR (1) TR200102877T2 (de)
WO (1) WO2000063252A1 (de)
ZA (1) ZA200107906B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (de) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
AU2002326751A1 (en) 2001-08-13 2003-03-03 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
US7718772B2 (en) * 2006-12-14 2010-05-18 Schering-Plough Animal Health Corporation Canine thymic stromal lymphopoietin protein and uses thereof
PT3023438T (pt) 2009-09-03 2020-05-08 Merck Sharp & Dohme Anticorpos anti-gitr
DK2473605T3 (en) * 2009-09-03 2018-05-28 Pfizer Vaccines Llc PCSK9-VACCINE
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
JP7554759B2 (ja) * 2019-02-26 2024-09-20 ソレント・セラピューティクス・インコーポレイテッド Ｂｃｍａに結合する抗原結合性タンパク質

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0141783B2 (de) 1983-11-07 1993-06-16 The Wistar Institute Durch antiidiotype Antikörper induzierte immune Antwort zu Tumoren und Viren
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
DE122006000007I2 (de) * 1987-12-31 2008-03-27 Tanox Inc -tragenden b-lymphocyten befinden.
SG70982A1 (en) 1990-01-23 2000-03-21 Tanox Biosystems Inc Extracellular segments of human and immunoglobulin anchoring peptides and antibodies specific therefor
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
AU681360B2 (en) 1992-09-30 1997-08-28 Scripps Research Institute, The Human neutralizing monoclonal antibodies to human immunodeficiency virus
CA2245497C (en) * 1996-03-01 2009-02-24 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
WO1999055911A1 (en) 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)

Also Published As

Publication number Publication date
ATE392437T1 (de) 2008-05-15
AR029624A1 (es) 2003-07-10
AU3966000A (en) 2000-11-02
NO20014936L (no) 2001-12-03
US7041288B2 (en) 2006-05-09
JP4109829B2 (ja) 2008-07-02
IL145507A (en) 2008-11-03
PL350676A1 (en) 2003-01-27
RU2253655C2 (ru) 2005-06-10
ES2302693T3 (es) 2008-08-01
GB9908533D0 (en) 1999-06-09
CN1346372A (zh) 2002-04-24
HUP0200713A2 (en) 2002-07-29
DE60038608T2 (de) 2009-06-10
DE60038608D1 (de) 2008-05-29
JP2002544125A (ja) 2002-12-24
CA2363991C (en) 2010-06-08
EP1169353A1 (de) 2002-01-09
TR200102877T2 (tr) 2002-01-21
ZA200107906B (en) 2003-08-27
CO5241329A1 (es) 2003-01-31
CA2363991A1 (en) 2000-10-26
CZ20013673A3 (cs) 2002-05-15
EP1169353B1 (de) 2008-04-16
HK1044544A1 (en) 2002-10-25
NO20014936D0 (no) 2001-10-10
CN1268644C (zh) 2006-08-09
MY141459A (en) 2010-04-30
PT1169353E (pt) 2008-07-14
KR20020007366A (ko) 2002-01-26
WO2000063252A1 (en) 2000-10-26
HK1044544B (en) 2008-11-21
IL145507A0 (en) 2002-06-30
US20020141989A1 (en) 2002-10-03
BR0009781A (pt) 2002-01-08
AU767712B2 (en) 2003-11-20
PE20010046A1 (es) 2001-02-23
MXPA01010348A (es) 2002-10-23
KR100492202B1 (ko) 2005-06-03

Similar Documents

Publication Publication Date Title
EP0885244B1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
EP1169353B1 (de) Anti-idiotypische antikörper gegen antikörper, welche die bindung zwischen immunoglobulin e und seinem hochaffinitätsrezeptor hemmen
JP6277125B2 (ja) ホスホリルコリンに対する新規抗体
JP6277126B2 (ja) ホスホリルコリン（ｐｃ）および／またはｐｃコンジュゲートに結合する抗体
CZ20013082A3 (cs) Peptid
RU2717989C1 (ru) Моноклональное антиидиотипическое антитело АИ-G1, обладающее антигенными свойствами морфина
US20050214285A1 (en) Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
JP2020505334A (ja) 治療抗ＩｇＥ抗体並びにその方法及び組成物
HK1199409B (en) Antibodies binding to phosphorylcholine (pc) and/or pc conjugates
HK1014962B (en) Peptide immunogens for vaccination against and treatment of allergy